Aralez Pharmaceuticals Inc (ARZ) Shares Down 5.4%
Aralez Pharmaceuticals Inc (TSE:ARZ) dropped 5.4% on Tuesday . The stock traded as low as C$2.68 and last traded at C$2.78. Approximately 20,503 shares traded hands during trading, a decline of 68% from the average daily volume of 63,640 shares. The stock had previously closed at C$2.94.
The firm has a 50 day moving average of $2.32 and a 200 day moving average of $2.32. The firm’s market capitalization is $179.15 million.
TRADEMARK VIOLATION NOTICE: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/10/12/aralez-pharmaceuticals-inc-arz-shares-down-5-4.html.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Stock Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.